Pharmacor will be allowed to sell a generic version of heart drug Entresto after the Full Court rejected Swiss drug giant Novartis’ appeal of a ruling that found an extension of the term of its patent for the drug was invalidly granted.
A group member in a class action against Johnson & Johnson unit DePuy has filed an appeal after he lost a challenge to his compensation determination, 12 years after the case settled.
A judge recently made the rare decision to declass a representative case, and experts say we may see more of the difficult applications as class actions move into areas with greater variation in the circumstances of group members.
A Toyota flex commissions class action can’t retroactively join claims about alleged junk insurance made in a separate case to protect against a limitations defence, with a judge describing such applications as “prima facie vexatious”.
A judge has found that three directors at ASX-listed investment firm Keybridge Capital were validly removed and replaced at a meeting last month.
The ACCC has found Coles and Woolworths operate as an oligopoly with “little incentive” to compete but has stopped short of recommending a break-up or similar strong measures, saying there is no “silver bullet”.
A judge has refused to vacate a trial next month in a case against a law firm and a barrister by a former client, despite the agreement of all parties to push off the hearing.
News Corp has agreed to removed posts that allegedly defamed a senior member of the Hells Angels bikie gang by labelling him a “cocaine kingpin” and “fugitive from justice”.
Australian building materials giant James Hardie will acquire US-based home decking provider AZEK in a nearly $14 billion merger.
Former directors of collapsed Sydney developer Dyldam have been targeted by a liquidator over claims allegedly worth at least $33 million.